Randomized Trial of Zileuton for Treatment of COPD Exacerbations Requiring Hospitalization

RATIONALE: Leukotrienes have been implicated in the pathogenesis of acute exacerbations of COPD, but leukotriene modifiers have not been studied as a possible therapy for exacerbations. OBJECTIVE: We sought to test the safety and efficacy of adding oral zileuton (a 5-lipoxygenase inhibitor) to usual...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Woodruff, Prescott G., Albert, Richard K., Bailey, William C., Casaburi, Richard, Connett, John E., Cooper, John A. D., Criner, Gerard J., Curtis, Jeffrey L., Dransfield, Mark T., Han, Meilan K., Harnden, Sarah M., Kim, Victor, Marchetti, Nathaniel, Martinez, Fernando J., McEvoy, Charlene E., Niewoehner, Dennis E., Reilly, John J., Rice, Kathryn, Scanlon, Paul D., Scharf, Steven M., Sciurba, Frank C., Washko, George R., Lazarus, Stephen C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3775706/
https://ncbi.nlm.nih.gov/pubmed/21299475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/15412555.2010.540273
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak